| Market Cap | €449.6M | |
| Enterprise Value | — | |
| Revenue | €145.2M | −7.3% |
| Gross Profit | — | — |
| EBITDA | €74.1M | −32.0% |
| Net Income | -€30.1M | — |
| Diluted EPS | €0.27 | −63.2% |
| Free Cash Flow | €27.4M | −50.0% |
| DPS (FY2023) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| FY20202020-12-31 | — | — | reported |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | Trend · 5y | vs own |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| EBITDA Margin | — | — | 68.56% | 69.55% | 51.01% | 17% | |
| NOPAT Margin | — | — | 4.27% | −16.43% | 20.52% | 83% | |
| Net Margin | −48.68% | 34.72% | −14.68% | −52.16% | −20.71% | 50% | |
| FCF Margin | 25.67% | 39.66% | 33.51% | 34.97% | 18.86% | 10% | |
| FCFE Margin | 14.33% | −41.99% | −55.16% | 13.75% | −102.52% | 10% | |
| OCF Margin | 35.39% | 51.77% | 54.60% | 49.38% | 31.99% | 10% | |
| Capex Intensity | 9.72% | 12.12% | 21.09% | 14.41% | 13.12% | 50% | |
| ▸Returns on Capital · 3 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||
| ▸Earnings quality · 6 ratios | |||||||
| ▸Liquidity & coverage · 6 ratios | |||||||
| ▸Leverage · 2 ratios | |||||||
| ▸Working capital · 1 ratios | |||||||
| ▸Capital allocation · 2 ratios | |||||||
| Line | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | €152.7M | €152.0M | €152.0M | €156.7M | €145.2M |
| YoY % | -0.5% | +0.0% | +3.1% | -7.3% | |
| Total Operating Expenses | €46.0M | €45.6M | €43.6M | €43.2M | €41.2M |
| YoY % | -0.8% | -4.4% | -0.8% | -4.7% | |
| Interest Expense | — | — | €30.6M | €49.2M | €67.5M |
| YoY % | +60.9% | +37.3% | |||
| Interest & Investment Income | — | — | €92,000 | €514,000 | €392,000 |
| YoY % | +458.7% | -23.7% | |||
| Pretax Income | -€88.5M | €55.8M | -€22.3M | -€81.8M | -€29.8M |
| Income Tax | -€14.2M | €3.0M | -€18,000 | -€31,000 | €288,000 |
| Income from Continuing Operations | -€52.3M | €88.7M | €7.7M | -€33.1M | €66.5M |
| YoY % | -91.3% | ||||
| Net Income (incl. NCI) | -€74.3M | €52.8M | -€22.3M | -€81.7M | -€30.1M |
| Minority Interest (P&L) | — | €0 | €0 | €0 | €0 |
| Net Income | -€74.3M | €52.8M | -€22.3M | -€81.7M | -€30.1M |
| EPS (Basic) | -€0.67 | €0.48 | -€0.20 | -€0.74 | -€0.27 |
| EPS (Diluted) | €0.67 | -€0.48 | €0.20 | €0.74 | €0.27 |
| YoY % | +266.8% | -63.2% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
